Trials that use: Risk ratio / relative risk
New to this method? Read the tutorial →
6,204 results
- Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Safety Study Of Tofacitinib In Patients With Juvenile Idiopathic Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Long-Term Study of Gabapentin Enacarbil (GEn, XP13512) vs. Placebo in Patients With Restless Legs Syndrome.: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Study of Gabapentin Enacarbil (GEn, XP13512) vs. Placebo in Patients With Restless Legs Syndrome.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Long-term Treatment Study of Certolizumab Pegol (CDP870) as Add-on Medication to Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients: Complete Statistical AnalysisIndependent statistical analysis of Long-term Treatment Study of Certolizumab Pegol (CDP870) as Add-on Medication to Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Long-term Use of Takepron on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Complete Statistical AnalysisIndependent statistical analysis of Long-term Use of Takepron on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Longitudinal Follow-up of High School Athletes: Complete Statistical AnalysisIndependent statistical analysis of Longitudinal Follow-up of High School Athletes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02432183).
- Longitudinal Outcome in a Veterans Geriatric Multifactorial Falls Assessment Clinic: Complete Statistical AnalysisIndependent statistical analysis of Longitudinal Outcome in a Veterans Geriatric Multifactorial Falls Assessment Clinic: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02356211).
- Longitudinal Study of Dental Implant Therapy in HIV Positive Patients: Complete Statistical AnalysisIndependent statistical analysis of Longitudinal Study of Dental Implant Therapy in HIV Positive Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01211288).
- Lopinavir/Ritonavir (Kaletra) PK in Children: Complete Statistical AnalysisIndependent statistical analysis of Lopinavir/Ritonavir (Kaletra) PK in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00810108).
- Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery: Complete Statistical AnalysisIndependent statistical analysis of Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- LOTIS-2Independent statistical analysis of Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval,…
- LOTIS-9Independent statistical analysis of A Study of Loncastuximab Tesirine and Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Participants With Diffuse Large B-cell Lymphoma (DLBCL): primary endpoint results, effect estimate with confidence interval, sample-size…
- Low Cost QTc Meter for Long QT Syndrome Screening in Primary Care: Complete Statistical AnalysisIndependent statistical analysis of Low Cost QTc Meter for Long QT Syndrome Screening in Primary Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Low Dose Arsenic Trioxide as a Potential Chemotherapy Protector: Complete Statistical AnalysisIndependent statistical analysis of Low Dose Arsenic Trioxide as a Potential Chemotherapy Protector: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01428128).
- Low Dose Parenteral Fat for Prevention of Parenteral Nutrition Associated Cholestasis in Preterm Neonates: Complete Statistical AnalysisIndependent statistical analysis of Low Dose Parenteral Fat for Prevention of Parenteral Nutrition Associated Cholestasis in Preterm Neonates: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Low Dose Thymoglobin in Renal Transplant Patients: Complete Statistical AnalysisIndependent statistical analysis of Low Dose Thymoglobin in Renal Transplant Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01280617).
- Low-dose IL-2( Interleukin-2) Treatment in SLE: Complete Statistical AnalysisIndependent statistical analysis of Low-dose IL-2( Interleukin-2) Treatment in SLE: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02084238).
- Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease: Complete Statistical AnalysisIndependent statistical analysis of Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Low-Dose Radiation Therapy to the Whole Liver With Gemcitabine and Cisplatin in IHC: Complete Statistical AnalysisIndependent statistical analysis of Low-Dose Radiation Therapy to the Whole Liver With Gemcitabine and Cisplatin in IHC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Low-Dose Versus High-Dose Oxytocin Dosing for Induction and Augmentation of Labor: Complete Statistical AnalysisIndependent statistical analysis of Low-Dose Versus High-Dose Oxytocin Dosing for Induction and Augmentation of Labor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Low-Level Laser Therapy for Prevention of Oral Mucositis: Complete Statistical AnalysisIndependent statistical analysis of Low-Level Laser Therapy for Prevention of Oral Mucositis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02682992).
- LSA4 Protocol for the Treatment of Advanced Pediatric and Adolescent Non-Hodgkins Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of LSA4 Protocol for the Treatment of Advanced Pediatric and Adolescent Non-Hodgkins Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- LUCENT 2Independent statistical analysis of A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- LUDICASIndependent statistical analysis of Characteristics of Sexual Dysfunction in Patients With Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06018376).
- Lung Cancer Screening Eligibility Assessment: Complete Statistical AnalysisIndependent statistical analysis of Lung Cancer Screening Eligibility Assessment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06133816).
- Lung Volume Reduction for Severe Emphysema by Stereotactic Ablative Radiation Therapy: Complete Statistical AnalysisIndependent statistical analysis of Lung Volume Reduction for Severe Emphysema by Stereotactic Ablative Radiation Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer: primary endpoint results, effect estimate with confidence…
- Lusedra (Fospropofol Disodium) for Minimal to Moderate Sedation for Regional Anesthesia Block Prior to Orthopedic Surgery: Complete Statistical AnalysisIndependent statistical analysis of Lusedra (Fospropofol Disodium) for Minimal to Moderate Sedation for Regional Anesthesia Block Prior to Orthopedic Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures: Complete Statistical AnalysisIndependent statistical analysis of LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial): Complete Statistical AnalysisIndependent statistical analysis of LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05780268).
- Lyophilized IMVAMUNE® (1×10^8 TCID50) Versus Liquid IMVAMUNE® (1×10^8 TCID50) Administered Subcutaneously and a Lower Dose Liquid IMVAMUNE® (2×10^7 TCID50) Administered Intradermally: Complete Statistical AnalysisIndependent statistical analysis of Lyophilized IMVAMUNE® (1x10^8 TCID50) Versus Liquid IMVAMUNE® (1x10^8 TCID50) Administered Subcutaneously and a Lower Dose Liquid IMVAMUNE® (2x10^7 TCID50) Administered Intradermally: primary endpoint results, effect estimate with confidence…
- M-MILKIndependent statistical analysis of Multisensory Early Oral Administration of Human Milk in Preterm Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06230848).
- M-RePoRTIndependent statistical analysis of Metformin for Rising PSA Remote Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02376166).
- M032-HSV-1Independent statistical analysis of Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- M2-ABMGIndependent statistical analysis of A Study to Evaluate the Safety and Immunogenicity of Oral Polio Vaccine Type 2 in Infants and Children: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- M3541 in Combination With Radiotherapy in Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of M3541 in Combination With Radiotherapy in Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03225105).
- MA181Independent statistical analysis of Assessing Choice in the Employer Setting (ACES) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00808808).
- MACH19Independent statistical analysis of RCT of Mushroom Based Natural Product to Enhance Immune Response to COVID-19 Vaccination: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MACS0911Independent statistical analysis of Study to Evaluate Nilotinib in Chronic Myelogenous Leukemia (CML) Patients With SubOptimal Response: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MADIndependent statistical analysis of Magnetic Anastomosis Device Relief of Malignant Gastric Outlet Obstruction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00487552).
- MAGE-A3 Protein + AS15 as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation: Complete Statistical AnalysisIndependent statistical analysis of MAGE-A3 Protein + AS15 as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MAGE-A4ᶜ¹º³²T for Multi-Tumor: Complete Statistical AnalysisIndependent statistical analysis of MAGE-A4ᶜ¹º³²T for Multi-Tumor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03132922).
- MAGELLAN-3Independent statistical analysis of Efficacy and Safety of Glecaprevir (ABT-493)/Pibrentasvir (ABT 530) (GLE/PIB) in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in…
- Magnesium vs Placebo for Tonsillectomy: Complete Statistical AnalysisIndependent statistical analysis of Magnesium vs Placebo for Tonsillectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02218424).
- MAGNET (Magnetically Controlled Capsule for Assessment of Gastric Mucosa in Symptomatic Patients): Complete Statistical AnalysisIndependent statistical analysis of MAGNET (Magnetically Controlled Capsule for Assessment of Gastric Mucosa in Symptomatic Patients): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Magnetic Resonance Imaging (MRI) Brachytherapy Applicator Study: Complete Statistical AnalysisIndependent statistical analysis of Magnetic Resonance Imaging (MRI) Brachytherapy Applicator Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01706705).
- Magnetic Resonance Imaging of the Liver in Children 0-2 Months of Age With an Intravenous Injection of Eovist/Primovist Which is a Contrast Agent: Complete Statistical AnalysisIndependent statistical analysis of Magnetic Resonance Imaging of the Liver in Children 0-2 Months of Age With an Intravenous Injection of Eovist/Primovist Which is a Contrast Agent: primary endpoint results, effect estimate…
- Magnetic Resonance Imaging Study of Lisdexamfetamine for Bipolar Depression: Complete Statistical AnalysisIndependent statistical analysis of Magnetic Resonance Imaging Study of Lisdexamfetamine for Bipolar Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01051440).
- Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma: Complete Statistical AnalysisIndependent statistical analysis of Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- MAGNIFYIndependent statistical analysis of Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- MAGNITUDEIndependent statistical analysis of Safety and Efficacy Study in Subjects With Chronic HCV and Underlying Hemophilia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…